Figure 5.

IL-17 increases p38 MAPK level in NSCs. NSCs were cultured at 400 cells/ml in 6-well plates and treated with IL-17 for 48 h, as described in Materials and Methods. SB203580 was added to culture medium 2 h before IL-17 was added. (a) Newly formed NSCs treated with IL-17 (25 ng/ml), with or without addition of SB203580 (15 μM). (b) Number of NSCs treated with IL-17 (25 ng/ml), with or without addition of SB203580 (15 μM). (c) Western blot for p38 MAPK level in NSCs. Mean percentages were determined from three independent experiments. NS, not significant.

Li et al. BMC Immunology 2013 14:20   doi:10.1186/1471-2172-14-20
Download authors' original image